Patent: 5,460,812
✉ Email this page to a colleague
Summary for Patent: 5,460,812
| Title: | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| Abstract: | Disclosed are gastric acid-resistant polymer-coated buffered digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods of treating digestive disorders, pancreatic enzyme insufficiency, impaired liver function, cystic fibrosis, for regulating the absorption of dietary iron and cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment. |
| Inventor(s): | Sipos; Tibor (Lebanon, NJ) |
| Assignee: | Digestive Care Inc. (Lebanon, NJ) |
| Application Number: | 08/129,250 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,460,812
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Discure Medical, Llc | CHYMODIACTIN | chymopapain | For Injection | 018663 | November 10, 1982 | ⤷ Start Trial | 2013-09-29 |
| Discure Medical, Llc | CHYMODIACTIN | chymopapain | For Injection | 018663 | August 21, 1984 | ⤷ Start Trial | 2013-09-29 |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | December 09, 1996 | ⤷ Start Trial | 2013-09-29 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | April 30, 2009 | ⤷ Start Trial | 2013-09-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,460,812
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 5578304 | ⤷ Start Trial |
| United States of America | 5324514 | ⤷ Start Trial |
| United States of America | 5260074 | ⤷ Start Trial |
| European Patent Office | 0576938 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
